These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 30762079)
1. Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation. Rahamimov R; Tifti-Orbach H; Zingerman B; Green H; Schneider S; Chagnac A; Mor E; Fox BD; Rozen-Zvi B Eur J Clin Pharmacol; 2019 Jul; 75(7):951-958. PubMed ID: 30762079 [TBL] [Abstract][Full Text] [Related]
2. Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation. Rozen-Zvi B; Schneider S; Lichtenberg S; Green H; Cohen O; Gafter U; Chagnac A; Mor E; Rahamimov R Nephrol Dial Transplant; 2017 Feb; 32(2):393-399. PubMed ID: 28025383 [TBL] [Abstract][Full Text] [Related]
3. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation. Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH Front Immunol; 2021; 12():746013. PubMed ID: 34659243 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. Sapir-Pichhadze R; Wang Y; Famure O; Li Y; Kim SJ Kidney Int; 2014 Jun; 85(6):1404-11. PubMed ID: 24336032 [TBL] [Abstract][Full Text] [Related]
6. The Number of Episodes of Subtherapeutic Tacrolimus Blood Level Is Independently Associated With Reduced Kidney Graft Survival. Meisel E; Bielopolski D; Steinmetz T; Agur T; Lichtenberg S; Goldman S; Herman-Edelstein M; Nesher E; Rahamimov R; Rozen-Zvi B Clin Transplant; 2024 Sep; 38(9):e15460. PubMed ID: 39302223 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score-Matched Analysis. Yin S; Song T; Jiang Y; Li X; Fan Y; Lin T Ther Drug Monit; 2019 Jun; 41(3):308-316. PubMed ID: 31083041 [TBL] [Abstract][Full Text] [Related]
9. Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience. Rhu J; Lee KW; Park H; Park JB; Kim SJ; Choi GS Ann Transplant; 2017 Nov; 22():707-718. PubMed ID: 29180612 [TBL] [Abstract][Full Text] [Related]
10. Exposure to tacrolimus trough levels below 6 ng/ml during the first year is associated with inferior kidney graft survival. Agur T; Rahamimov R; Zingerman B; Bielopolski D; Lichtenberg S; Nesher E; Rozen-Zvi B Clin Transplant; 2023 Mar; 37(3):e14879. PubMed ID: 36480165 [TBL] [Abstract][Full Text] [Related]
11. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. Rodrigo E; Segundo DS; Fernández-Fresnedo G; López-Hoyos M; Benito A; Ruiz JC; de Cos MA; Arias M Transplantation; 2016 Nov; 100(11):2479-2485. PubMed ID: 26703349 [TBL] [Abstract][Full Text] [Related]
12. Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. Žilinská Z; Dedinská I; Breza J; Laca L Transplant Proc; 2016 Oct; 48(8):2637-2643. PubMed ID: 27788794 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation. Xie W; Fan S; Liu R; Yan W; Su C; Zheng K; Wang X; Wang Z Transplant Rev (Orlando); 2024 Jul; 38(3):100842. PubMed ID: 38537484 [TBL] [Abstract][Full Text] [Related]
14. Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation. Park Y; Lee H; Eum SH; Ko EJ; Min JW; Yoon SH; Hwang WM; Yun SR; Yang CW; Shin J; Chung BH Front Immunol; 2022; 13():1037566. PubMed ID: 36466843 [TBL] [Abstract][Full Text] [Related]
15. Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation. Ro H; Min SI; Yang J; Moon KC; Kim YS; Kim SJ; Ahn C; Ha J Ther Drug Monit; 2012 Dec; 34(6):680-5. PubMed ID: 23149441 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation. Yin S; Wang X; Huang Z; Fan Y; Song T; Lin T Br J Clin Pharmacol; 2022 Jan; 88(1):75-83. PubMed ID: 33899267 [TBL] [Abstract][Full Text] [Related]